ZS PHARMA INC's ticker is ZSPH and the CUSIP is 98979G105. A total of 8 filers reported holding ZS PHARMA INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $525,000 | -92.3% | 8,000 | -93.9% | 0.10% | -84.5% |
| Q2 2015 | $6,847,000 | +19.9% | 130,700 | -3.7% | 0.64% | +19.7% |
| Q1 2015 | $5,710,000 | -2.2% | 135,700 | -3.4% | 0.54% | -3.8% |
| Q4 2014 | $5,841,000 | +3.8% | 140,500 | -2.0% | 0.56% | -3.6% |
| Q3 2014 | $5,626,000 | +22.3% | 143,400 | -10.4% | 0.58% | +47.1% |
| Q2 2014 | $4,600,000 | – | 160,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 564,483 | $22,145,000 | 2.62% |
| Redmile Group, LLC | 474,132 | $18,600,000 | 2.15% |
| Novo Holdings A/S | 506,730 | $19,879,000 | 1.94% |
| Ghost Tree Capital, LLC | 85,000 | $3,335,000 | 1.81% |
| VHCP Management, LLC | 100,000 | $3,923,000 | 1.76% |
| Atika Capital Management LLC | 31,000 | $1,216,000 | 0.94% |
| PFM Health Sciences, LP | 729,044 | $28,600,000 | 0.66% |
| WALL STREET ASSOCIATES | 143,400 | $5,626,000 | 0.58% |
| Rock Springs Capital Management LP | 92,000 | $3,609,000 | 0.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 136,204 | $5,343,000 | 0.51% |